The researchers sought to compare whether premutation carrier women and control individuals differ in the severity of neuromotor signs associated with FXTAS and if this severity is also associated with advanced age.
All articles by melissaalvarez
Latest News Your top articles for ThursdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses